BEOVU
120MG/ML INJ SOL 1X0,230ML+1J
| SÚKL code | 0238814 |
|---|---|
| Name of the product | BEOVU |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | BEOVU |
| Supplement | 120MG/ML INJ SOL 1X0,230ML+1J |
| Strenght | 120MG/ML |
| Pharmaceutical form | Solution for injection |
| Package | 1X0,230ML+1J |
| Route | Intravitreal use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | BROLUCIZUMAB (BROLUCIZUMABUM) |
| ATC group | S01LA06 |
| ATC group name | BROLUCIZUMAB |
Marketing authorisation information
| Registration Number | EU/1/19/1417/002 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Novartis Europharm Limited, Dublin |
| MA Holder country | IRSKO |
cz